Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer. (nejm.org)

Authors: Loibl S … Geyer CE Jr Journal: New England Journal of Medicine Published: 2026-02-26 DOI: https://doi.org/10.1056/NEJMoa2514661